| Irinotecan in Treating Children With Refractory Solid Tumors (NCT00004078) | Children's Oncology Group | 1999-10-01 |
| DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas (NCT00004212) | Daiichi Sankyo | 1999-09-01 |
| Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy (NCT00003739) | Children's Oncology Group | 1999-03-01 |
| Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant (NCT00003894) | Roswell Park Cancer Institute | 1999-03-01 |
| Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation (NCT00003898) | Roswell Park Cancer Institute | 1999-01-01 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer (NCT00003816) | Roswell Park Cancer Institute | 1998-10-19 |
| Irinotecan in Treating Children With Refractory or Progressive Solid Tumors (NCT00016861) | Texas Children's Cancer Center | 1998-09-01 |
| Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers (NCT00003754) | Memorial Sloan Kettering Cancer Center | 1998-09-01 |
| Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors (NCT00003288) | National Cancer Institute (NCI) | 1998-08-01 |
| Irofulven in Treating Children With Recurrent or Refractory Solid Tumors (NCT00003370) | National Cancer Institute (NCI) | 1998-08-01 |
| Arsenic Trioxide in Treating Patients With Advanced Solid Tumors (NCT00003630) | Memorial Sloan Kettering Cancer Center | 1998-08-01 |
| Fenretinide in Treating Children With Solid Tumors (NCT00003191) | National Cancer Institute (NCI) | 1998-03-01 |
| High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors (NCT00003173) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003194) | Seattle Children's Hospital | 1997-07-01 |
| Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors (NCT00003073) | Pacira Pharmaceuticals, Inc | 1997-02-01 |
| Gemcitabine in Treating Children With Refractory Solid Tumors (NCT00005577) | National Cancer Institute (NCI) | 1996-08-01 |
| Interferon Alfa in Treating Children With HIV-Related Cancer (NCT00002621) | Children's Oncology Group | 1994-12-01 |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate (NCT00018967) | National Cancer Institute (NCI) | 1993-11-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00060255) | Roswell Park Cancer Institute | 1991-12-01 |
| Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer (NCT00607802) | Wake Forest University Health Sciences | |